StockNews.AI
HAE
Benzinga
11 days

These Analysts Slash Their Forecasts On Haemonetics After Q1 Results

1. HAE reported Q1 earnings of $1.10, beating estimates. 2. Quarterly sales reached $321.394 million, exceeding expectations. 3. FY2026 EPS guidance reaffirmed between $4.70 and $5.00. 4. JP Morgan downgraded HAE from Overweight to Neutral. 5. Other analysts maintained rating but lowered price targets.

3m saved
Insight
Article

FAQ

Why Bearish?

Despite strong earnings, downgrades and lowered price targets indicate caution among analysts. Historical trends show that downgrades often lead to short-term price declines.

How important is it?

Earnings beat expectations, but downgrades highlight underlying market concerns affecting stock performance.

Why Short Term?

Analyst downgrades and reduced price targets can impact stock sentiment quickly, affecting investor behavior. Similar instances have previously shown immediate market reactions.

Related Companies

Related News